HealthTree Logo
search more_vert
person Sign In / Create Account
Reversing T-cell Exhaustion with Antioxidants 
Posted: Jun 13, 2023
Reversing T-cell Exhaustion with Antioxidants  image

Reversing T-cell Exhaustion with Antioxidants 

Can exhausted T-cells get re-activated by antioxidants? Can antioxidants be used to improve CAR T-cell therapy outcomes?  

Memorial Sloan Kettering Cancer Center (MSKCC) doctors in New York City, Drs. Santosha Vardhana, MD, PhD, and Craig B. Thompson, MD found evidence that balancing the body by reducing excess oxidative stress with antioxidants reverses T-cell exhaustion to help the T-cells work effectively at multiplying and destroying cancer cells. Their work is testing this concept in lymphoma. 

T-cells are the patient’s own cancer-killing immune system cells. CAR T-cell therapy helps enhance the patient’s T-cells to more effectively kill cancer cells. 

One of the reasons CAR T-cell therapy has had limitations in effectiveness is that the T-cells get exhausted, which causes them to stop multiplying and destroying cancer cells.

A strong correlation has been found between T-cell exhaustion and high oxidative stress. Reducing excess oxidative stress with antioxidants allows the T-cell's mitochondria not to be impaired by fatigue and be able to do their job of converting energy stores into energy, keeping the T-cell working. 

Drs. Vardhana and Thompson's findings are now being further reviewed in MSK’s lymphoma clinical trial using Yescarta combined with antioxidant N-AC (NCT05081479) led by Dr. Gunjan L. Shah, MD.

The success of the CAR T-cell exhaustion reversal is hoped to be replicated for other diseases like myeloma.

Clinical trials like these will be the best way to identify new strategies that can extend the promise of CAR T therapy. 

Further research will help define the appropriate dose of antioxidants to administer alongside CAR T-cell therapy for patients, allowing the cancer-killing immune system cells to work well while maintaining an appropriate oxidant/antioxidant balance. 

The author Megan Heaps

about the author
Megan Heaps

Megan joined HealthTree in 2022. As a writer and the daughter of a blood cancer patient, she is dedicated to helping patients and their caregivers understand the various aspects of their disease. This understanding enables them to better advocate for themselves and improve their treatment outcomes. In her spare time, she enjoys spending time with her family, sewing, and cooking.

Thanks to our HealthTree Community for Diffuse Large B Cell Lymphoma Sponsors:

Bristol Myers Squibb

Follow Us

facebook instagram youtube